Bionest Partners and Scisive merge to create "Best in Class" Global Life Science
Consulting firm (11th Dec 2012)
Bionest Partners, and Scisive Consulting, strategy and management consulting firms
for the life science industries announce their merger today.
Bionest and PMC Address Optimization of Personalized Medicine Strategies
Science article highlights a combination of business analytics and consensus
building for R&D and commercialization decisions.
Global Buyout Fund acquires 80% share in Bicakcilar
Bionest Partners serves as industry advisor for The Global BuyOut fund in its
acquisition of 80% share in Bicakcilar.
Graftys chooses Bionest Partners Finance as new financial partner (5th Jan 2011)
Graftys completes third round of financing for 4 million euros ($5,3 Million),
and adds a new financial partner.
Bionest appoints Damien Baur as Manager in corporate finance (14th October 2010)
Damien’s arrival in Bionest Partners corporate finance team reflects the company’s
long term commitment to serving existing and new clients needs in transactions.
Bionest Appoints Dr. Sean X. Hu as Managing Director, North America
This appointment reflects Bionest Partners’ commitment to expanding its
North American business with a major emphasis on personalized medicine.
Bionest Partners Finance advises Poxel in a Serie A financing of €16M
Advised by Bionest Partners Finance Poxel raises 16 million Euros through a prestigious
syndicate led by Edmond de Rothschild Investment Partners.
Marinomed Signs Collaboration with Boehringer Ingelheim
for Anti-Viral Nasal Spray Against Common Cold (28th June 2010)
Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim.
Bionest appoints Lionel Delaporte as Managing Partner (24th March 2010)
This appointment signals a period of strong demand from the biopharmaceutical and Pharmaceutical industry for strategic advisory services and solid growth for Bionest Partners
Reaching the bottom?
Financial Advisory Newsletter, Q2 - 2008
Private Equity Newsletter
1st Semester 2008 Review
VCs keep investing but the scope’s changing!
Financial Advisory Newsletter, Q1 - 2008
Bionest Partners advised EUSA PHARMA on antibody deal with GSK
April 3rd, 2008
Bionest Partners revenues grow 41% in 2007
April 3rd, 2008
Bionest Partners Outlines Winning Pathways for BioPharma companies in Oncology
November 14, 2007.
To request the 78-page full report, please click here
Biotech Avicena engages Bionest Partners (July 12 2007)
Biotech Avicena engages Bionest Partners and Rothschild as Strategic Advisors
Bionest announce the launch of BIONEST MPV™ (May 7 2007)
Bionest Partners will be introducing this week at BIO its "MPV™" (Market Pipeline Value), a new user friendly tool to value Biotech Companies
Bionest chairs BIO 2007 Super Session on pandemic flu
Bionest Partners chairs BIO 2007 Super Session on pandemic flu preparedness
Bionest: 135% growth in revenues in 2006
Bionest reported that it revenues reached an all-time record of €5.1M in 2006
Bionest mandated by the Quebec private investor, QFL
Bionest exclusively mandated by the Quebec private investor, QFL, to look
for European investment opportunities
Bionest further boosts pharma consulting activity
Appointment of Lionel Delaporte and expansion of pharma team will help maintain
Bionest revenue growth up 50 percent in 2005
Dr Daniel Teper appointed Managing Director of NorthAmerica to head up US
operations for Bionest Partners
Frédéric Desdouits joins Bionest as Managing Partner
Bionest Partners launches dedicated Start-up unit
Advisory and management services provider opens Bionest Start-up offices at former
Aventis site, now the Biocitech technology park
Bionest Partners' Executive in Residence Program makes network of experienced
managers available to healthcare industry
Experienced international healthcare executives provide need-specific management
skills to Bionest clients
Bionest Partners appoints Advisory Board
Leading industry figures provide support, advice and governance
to fast-growing consulting and management firm.
Bionest Partners appoints senior consultant in Corporate Finance and
Bionest Partners launches Medical Device Practice